PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 320.0
(3.23%)
IDR 320.0
(3.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 47.32 Billion IDR | -34.95% |
| 2022 | 62.22 Billion IDR | -64.76% |
| 2021 | 176.58 Billion IDR | 1943.0% |
| 2020 | 8.64 Billion IDR | 59.75% |
| 2019 | 5.41 Billion IDR | -96.92% |
| 2018 | 175.63 Billion IDR | 11.88% |
| 2017 | 156.98 Billion IDR | 34.69% |
| 2016 | 116.55 Billion IDR | -1.11% |
| 2015 | 117.85 Billion IDR | 79.83% |
| 2014 | 65.53 Billion IDR | 28.71% |
| 2013 | 50.91 Billion IDR | 81.67% |
| 2012 | 28.02 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 16.16 Billion IDR | -38.81% |
| 2024 Q1 | 26.41 Billion IDR | 452.97% |
| 2024 Q3 | 19.14 Billion IDR | 18.49% |
| 2023 Q1 | 19.66 Billion IDR | -5.84% |
| 2023 Q4 | 4.77 Billion IDR | -72.64% |
| 2023 Q3 | 17.45 Billion IDR | 55.89% |
| 2023 Q2 | 11.19 Billion IDR | -43.05% |
| 2023 FY | 40.47 Billion IDR | -34.95% |
| 2022 Q3 | 38.6 Billion IDR | 294.2% |
| 2022 Q4 | 20.88 Billion IDR | -45.9% |
| 2022 FY | 62.22 Billion IDR | -64.76% |
| 2022 Q1 | 14.4 Billion IDR | 287.33% |
| 2022 Q2 | -19.87 Billion IDR | -238.03% |
| 2021 Q2 | 66.37 Billion IDR | -2.64% |
| 2021 Q3 | 49.71 Billion IDR | -25.1% |
| 2021 Q4 | -7.68 Billion IDR | -115.46% |
| 2021 FY | 176.58 Billion IDR | 1943.0% |
| 2021 Q1 | 68.17 Billion IDR | 125.8% |
| 2020 FY | 8.64 Billion IDR | 59.75% |
| 2020 Q1 | 10.95 Billion IDR | 3853.37% |
| 2020 Q2 | -15.45 Billion IDR | -241.06% |
| 2020 Q3 | 5.69 Billion IDR | 136.85% |
| 2020 Q4 | -264.2 Billion IDR | -4739.13% |
| 2019 Q1 | 40.52 Billion IDR | 8.76% |
| 2019 FY | 5.41 Billion IDR | -96.92% |
| 2019 Q4 | 277.15 Million IDR | 100.38% |
| 2019 Q3 | -73.19 Billion IDR | -293.62% |
| 2019 Q2 | 37.8 Billion IDR | -6.71% |
| 2018 Q3 | 46.64 Billion IDR | -1.45% |
| 2018 FY | 175.63 Billion IDR | 11.88% |
| 2018 Q1 | 44.39 Billion IDR | 17.37% |
| 2018 Q2 | 47.33 Billion IDR | 6.63% |
| 2018 Q4 | 37.26 Billion IDR | -20.13% |
| 2017 FY | 156.98 Billion IDR | 34.69% |
| 2017 Q1 | 37.86 Billion IDR | -13.56% |
| 2017 Q2 | 38.58 Billion IDR | 1.91% |
| 2017 Q3 | 42.71 Billion IDR | 10.71% |
| 2017 Q4 | 37.82 Billion IDR | -11.46% |
| 2016 Q1 | 31.94 Billion IDR | -61.32% |
| 2016 FY | 116.55 Billion IDR | -1.11% |
| 2016 Q4 | 43.8 Billion IDR | 99.76% |
| 2016 Q3 | 21.92 Billion IDR | 16.14% |
| 2016 Q2 | 18.88 Billion IDR | -40.89% |
| 2015 Q2 | 58.78 Billion IDR | 337.06% |
| 2015 Q1 | 13.44 Billion IDR | -20.74% |
| 2015 FY | 117.85 Billion IDR | 79.83% |
| 2015 Q4 | 82.57 Billion IDR | 2567.14% |
| 2015 Q3 | 3.09 Billion IDR | -94.73% |
| 2014 Q2 | 16.12 Billion IDR | 24.73% |
| 2014 FY | 65.53 Billion IDR | 28.71% |
| 2014 Q4 | 16.96 Billion IDR | -13.01% |
| 2014 Q1 | 12.93 Billion IDR | 4.77% |
| 2014 Q3 | 19.5 Billion IDR | 20.95% |
| 2013 Q1 | 14.58 Billion IDR | 65.56% |
| 2013 Q3 | 20.04 Billion IDR | 5.96% |
| 2013 Q4 | 12.34 Billion IDR | -38.43% |
| 2013 FY | 50.91 Billion IDR | 81.67% |
| 2013 Q2 | 18.92 Billion IDR | 29.75% |
| 2012 FY | 28.02 Billion IDR | 0.0% |
| 2012 Q4 | 8.8 Billion IDR | -28.59% |
| 2012 Q3 | 12.33 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 211.43 Billion IDR | 77.617% |
| PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 230.959% |
| PT Medikaloka Hermina Tbk | 780.69 Billion IDR | 93.938% |
| PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | 96.079% |
| PT Murni Sadar Tbk | 15.2 Billion IDR | -211.237% |
| PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | 76.848% |
| PT Royal Prima Tbk | -4.62 Billion IDR | 1123.936% |
| PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | -60.444% |
| PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 97.262% |
| PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | 55.462% |